Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Genome integrity

An RNA link for METTL16 and DNA repair in PDAC

Nature Cancer volume 3, pages 1018–1020 (2022)Cite this article

Subjects

Increasing evidence links RNA methyltransferases to DNA damage repair. METTL16 is now shown to antagonize homologous recombination by preventing DNA-end resection via MRE11. Thus, METTL16 may represent a cancer vulnerability that can be used to identify patients able to benefit from combination therapies with DNA-damaging agents.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: PDAC tumors with high METTL16 are deficient in DNA repair and more sensitive to combination therapy.

References

  1. Alexandrov, L. B. et al. Nature 500, 415–421 (2013).

    Article  CAS  Google Scholar 

  2. Zeng, X. et al. Nat. Cancer https://doi.org/10.1038/s43018-022-00429-3 (2022).

    Article  PubMed  Google Scholar 

  3. Oza, A. M. et al. Lancet Oncol. 16, 87–97 (2015).

    Article  CAS  Google Scholar 

  4. Wilson, R. H. et al. Br. J. Cancer 116, 884–892 (2017).

    Article  CAS  Google Scholar 

  5. Bendell, J. et al. Ann. Oncol. 26, 804–811 (2015).

    Article  CAS  Google Scholar 

  6. Wang, X. et al. Nature 505, 117–120 (2014).

    Article  Google Scholar 

  7. Alarcon, C. R., Lee, H., Goodarzi, H., Halberg, N. & Tavazoie, S. F. Nature 519, 482–485 (2015).

    Article  CAS  Google Scholar 

  8. Lin, S., Choe, J., Du, P., Triboulet, R. & Gregory, R. I. Mol. Cell 62, 335–345 (2016).

    Article  CAS  Google Scholar 

  9. Zhou, K. I. et al. Mol. Cell 76, 70–81 e79 (2019).

    Article  CAS  Google Scholar 

  10. Pendleton, K. E. et al. Cell 169, 824–835 e814 (2017).

    Article  CAS  Google Scholar 

  11. Xiang, Y. et al. Nature 543, 573–576 (2017).

    Article  CAS  Google Scholar 

  12. Zhang, C. et al. Mol. Cell 79, 425–442 e427 (2020).

    Article  CAS  Google Scholar 

  13. Svobodova Kovarikova, A. et al. Cells 9, 360 (2020).

    Article  Google Scholar 

  14. Warda, A. S. et al. EMBO Rep. 18, 2004–2014 (2017).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Yale University School of Medicine, New Haven, CT, USA

    Marcelo Perez-Pepe & Claudio R. Alarcón

  2. Yale Cancer Biology Institute, Yale University, West Haven, CT, USA

    Marcelo Perez-Pepe & Claudio R. Alarcón

Authors
  1. Marcelo Perez-Pepe
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudio R. Alarcón
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claudio R. Alarcón.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Perez-Pepe, M., Alarcón, C.R. An RNA link for METTL16 and DNA repair in PDAC. Nat Cancer 3, 1018–1020 (2022). https://doi.org/10.1038/s43018-022-00434-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43018-022-00434-6

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer